1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CELLECTIS - ADR
3.42 0.09 (2.70%)
33,719
XNAS Volume

XNAS 13 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Cellectis (ADR) - CLLS - stock price prediction, stock price target, analyst ratings from 5 analysts

Cellectis (ADR) has a share price target of US$ 7, revenue growth forecast of 59.5%, and profit growth estimate of -63.1% for FY25, based on top 5 analyst calls.